INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 186 filers reported holding INOVIO PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 1.03 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $59,278 | -46.0% | 72,290 | +2.7% | 0.00% | 0.0% |
| Q4 2022 | $109,785 | +2.6% | 70,375 | +13.1% | 0.00% | 0.0% |
| Q3 2022 | $107,000 | +8.1% | 62,242 | +9.2% | 0.00% | 0.0% |
| Q2 2022 | $99,000 | -51.5% | 57,015 | +0.3% | 0.00% | -50.0% |
| Q1 2022 | $204,000 | -27.9% | 56,871 | +0.4% | 0.00% | 0.0% |
| Q4 2021 | $283,000 | -30.3% | 56,617 | -0.2% | 0.00% | -33.3% |
| Q3 2021 | $406,000 | -22.1% | 56,741 | +1.0% | 0.00% | -25.0% |
| Q2 2021 | $521,000 | -6.8% | 56,200 | -6.6% | 0.00% | -20.0% |
| Q1 2021 | $559,000 | +30.0% | 60,185 | +23.9% | 0.01% | +25.0% |
| Q4 2020 | $430,000 | -22.2% | 48,581 | +1.8% | 0.00% | -20.0% |
| Q3 2020 | $553,000 | -37.7% | 47,703 | +44.8% | 0.01% | -61.5% |
| Q2 2020 | $888,000 | – | 32,934 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|